BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16326118)

  • 1. Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel.
    Murphy SM; Palmer M; Poole MF; Padegimas L; Hunady K; Danzig J; Gill S; Gill R; Ting A; Sherf B; Brunden K; Stricker-Krongrad A
    J Pharmacol Toxicol Methods; 2006; 54(1):42-55. PubMed ID: 16326118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the rubidium efflux assay for preclinical identification of HERG blockade.
    Chaudhary KW; O'Neal JM; Mo ZL; Fermini B; Gallavan RH; Bahinski A
    Assay Drug Dev Technol; 2006 Feb; 4(1):73-82. PubMed ID: 16506891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade.
    Deacon M; Singleton D; Szalkai N; Pasieczny R; Peacock C; Price D; Boyd J; Boyd H; Steidl-Nichols JV; Williams C
    J Pharmacol Toxicol Methods; 2007; 55(3):238-47. PubMed ID: 17141530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.
    Huang XP; Mangano T; Hufeisen S; Setola V; Roth BL
    Assay Drug Dev Technol; 2010 Dec; 8(6):727-42. PubMed ID: 21158687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
    Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
    J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
    Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
    J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs.
    Yu Z; Klaasse E; Heitman LH; Ijzerman AP
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):78-86. PubMed ID: 24200993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel.
    Singleton DH; Boyd H; Steidl-Nichols JV; Deacon M; Groot MJ; Price D; Nettleton DO; Wallace NK; Troutman MD; Williams C; Boyd JG
    J Med Chem; 2007 Jun; 50(13):2931-41. PubMed ID: 17536794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
    Qu Y; Gao B; Fang M; Vargas HM
    J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach.
    Piper DR; Duff SR; Eliason HC; Frazee WJ; Frey EA; Fuerstenau-Sharp M; Jachec C; Marks BD; Pollok BA; Shekhani MS; Thompson DV; Whitney P; Vogel KW; Hess SD
    Assay Drug Dev Technol; 2008 Apr; 6(2):213-23. PubMed ID: 18471075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
    Sorota S; Zhang XS; Margulis M; Tucker K; Priestley T
    Assay Drug Dev Technol; 2005 Feb; 3(1):47-57. PubMed ID: 15798395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
    Guo L; Guthrie H
    J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a high-throughput fluorescence assay method for HERG potassium channel inhibition.
    Dorn A; Hermann F; Ebneth A; Bothmann H; Trube G; Christensen K; Apfel C
    J Biomol Screen; 2005 Jun; 10(4):339-47. PubMed ID: 15964935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of hERG potassium channel blockade by antipsychotics.
    Silvestre JS; Prous JR
    Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):457-65. PubMed ID: 17982510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated Patch-Clamp Methods for the hERG Cardiac Potassium Channel.
    Houtmann S; Schombert B; Sanson C; Partiseti M; Bohme GA
    Methods Mol Biol; 2017; 1641():187-199. PubMed ID: 28748465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
    Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
    Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.